Yes I believe you are right. China were accepted in June 2017 into the ICH, a world body created by drug regulatory organisations, institutions in the US, Europe, and Japan to facilitate collaboration, standardization, improvement of drug development practices.
Clinical trials are far cheaper and quicker to run in China.